Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data.

Kapoor S, Kaushik VV, Jain R, Rao VKR, Gharia M

Open source

DOI
10.1002/acr2.11067
Published
2019 Oct
Container
ACR open rheumatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr2.11067,
  title = {Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data.},
  author = {Kapoor S and Kaushik VV and Jain R and Rao VKR and Gharia M},
  year = {2019},
  journal = {ACR open rheumatology},
  doi = {10.1002/acr2.11067},
  url = {https://doi.org/10.1002/acr2.11067}
}

RIS

TY  - JOUR
TI  - Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data.
AU  - Kapoor S
AU  - Kaushik VV
AU  - Jain R
AU  - Rao VKR
AU  - Gharia M
PY  - 2019
JO  - ACR open rheumatology
DO  - 10.1002/acr2.11067
UR  - https://doi.org/10.1002/acr2.11067
ER  - 

APA

S, K., VV, K., R, J., VKR, R., & M, G. (2019). Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data.. ACR open rheumatology. https://doi.org/10.1002/acr2.11067

Source records